Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 14/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 14/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 14/20 | 0.42 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | CCR2 | P41597 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8791901 | 0.94 | ADRB2 (0.46) | ADRB2ADRB1ADRB3SERPINE1ADRA1D | |
| SCHEMBL8791244 | 0.92 | ADRB2 (0.48) | ADRB2ADRB1ADRB3SERPINE1CCR2 | |
| SCHEMBL8793347 | 0.92 | ADRB3 (0.52) | ADRB2ADRB1ADRB3ADRA1DADRA1A | |
| SCHEMBL8791814 | 0.91 | ADRB2 (0.45) | ADRB2ADRB1ADRB3SERPINE1ADRA1D | |
| SCHEMBL9037652 | 0.91 | ADRB2 (0.48) | ADRB2ADRB1ADRB3SERPINE1ADRA1D | |
| SCHEMBL8791979 | 0.91 | ADRB2 (0.45) | ADRB2ADRB1ADRB3SERPINE1ADRA1D | |
| SCHEMBL8791273 | 0.89 | ADRB2 (0.46) | ADRB2ADRB1ADRB3SERPINE1CCR2 | |
| SCHEMBL8792055 | 0.87 | ADRB2 (0.47) | ADRB2ADRB1ADRB3SERPINE1CCR2 | |
| SCHEMBL8792057 | 0.87 | ADRB2 (0.47) | ADRB2ADRB1ADRB3SERPINE1CCR2 | |
| SCHEMBL8791999 | 0.87 | ADRB2 (0.48) | ADRB2ADRB1ADRB3SERPINE1CCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0703911-B1 | SECONDARY AMINES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | PFIZER (US) | 1997-07-02 | — | — | EP | disclosed |